SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1MEF - Registration adding securities to prior Form S-1 registration [Rule 462(b)]:
SEC Accession No. 0001683168-23-004108
Filing Date
2023-06-14
Accepted
2023-06-14 08:30:36
Documents
4
Effectiveness Date
2023-06-14

Document Format Files

Seq Description Document Type Size
1 FORM S-1 MEF coeptis_s1mef.htm S-1MEF 36926
2 OPINION AND CONSENT OF COUNSEL coeptis_ex0501.htm EX-5.1 15999
3 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM coeptis_ex2301.htm EX-23.1 2991
4 CALCULATION OF FILING FEE TABLES coeptis_ex0107.htm EX-FILING FEES 16107
  Complete submission text file 0001683168-23-004108.txt   73169
Mailing Address 105 BRADFORD ROAD, SUITE 420 WEXFORD PA 15090
Business Address 105 BRADFORD ROAD, SUITE 420 WEXFORD PA 15090 724-934-6467
Coeptis Therapeutics Holdings, Inc. (Filer) CIK: 0001759186 (see all company filings)

IRS No.: 981465952 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1MEF | Act: 33 | File No.: 333-272631 | Film No.: 231013057
SIC: 2836 Biological Products, (No Diagnostic Substances)